Skip to content

Antioxidant serum improved early recovery markers after acne-scar laser treatment

In a trial comparing opposite sides of the face, the serum side had more complete scab shedding than the saline side. The study did not assess scar improvement.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

After laser treatment, skin receiving the antioxidant serum showed more complete scab detachment and better measured redness, pigmentation and hydration outcomes than skin receiving saline. This supports an early recovery effect in the studied patients. It does not tell us whether scars improved more, whether benefits persisted, or which application frequency was better.

Keep in mind

Follow-up covered only 14 days, and scar improvement was explicitly outside the study's scope. The abstract gives no separate results for the application-frequency subgroups or details of adverse events.

THE NUMBERS, WITH CONTEXT

What researchers found

60.9% vs. 34.4%

Complete scab detachment

At Day 7 after laser treatment: serum-treated side versus saline-treated side; proportions with complete detachment, p = 0.0026.

J Cosmet Dermatol, 2026 · Original source ↓

A comparison within each person

Each patient received serum on one facial side and saline on the other after the same laser procedure. Investigators assessing the results were blinded, and the analysis focused on local skin recovery measures.

What the skin measurements mean

The serum side had greater reductions in measured redness and pigment indices, alongside better hydration and water-loss results. These measures describe recovery after the procedure; they do not directly measure changes in acne-scar appearance.

CHECK THE ORIGINAL

The original publication

Reparative Effects of a Topical Antioxidant Serum Containing Vitamin C, Vitamin E, and Ferulic Acid After Ablative Fractional CO2 Laser Treatment for Atrophic Acne Scars: A Randomized, Investigator-Blinded, Split-Face, Controlled Trial.

Shi Y, Xu S, Zhang W
J Cosmet Dermatol · 2026

PubMed ID
41521693
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.